# The Effect of Remifentanil on Established Capsaicin-Induced Hyperalgesia in Human Volunteers

> **NCT00789386** · PHASE4 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 24 (estimated)

## Conditions studied

- Hyperalgesia

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT00789386
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2009-10
- **Final completion:** 2009-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2009-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789386, "The Effect of Remifentanil on Established Capsaicin-Induced Hyperalgesia in Human Volunteers". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00789386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*